Hernia etiology has been attributed to a miscellany of causes including mechanical strain, prior surgical intervention, abnormal embryologic development, and increased intraabdominal pressure. Whereas the most common inciting cause in ventral hernias is previous abdominal surgery, with an incidence between 3% and 11% after laparotomy procedures,^[@R1],\ [@R2]^ other factors associated with the development of abdominal wall hernias include wound infections,^[@R3]^ increasing age, obesity,^[@R4]^ and method of wound closure.^[@R5]^ Clearly, the pathophysiology of hernia development is multifactorial, as some indirect hernias do not develop until late in life and not all patients with laparotomy develop hernias after laparotomy. To identify the biologic culprit of hernia formation, multiple authors have suggested a qualitative or quantitative defect in collagen formation as a common factor. We explore this etiology through an examination of the histopathologic evidence and evaluation of patients with collagen vascular diseases, such as Ehlers--Danlos syndrome and Marfan's syndrome (Fig. [1](#F1){ref-type="fig"}).
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BACKGROUND
==========

Ehlers--Danlos syndrome is an inherited disorder of connective tissue that has been divided into six types, based on the defect in collagen metabolism.^[@R6]^ Named for Henri-Alexandre Danlos and Edvard Ehlers' 1908 description of the disease, this syndrome is generally associated with skin hyperextensibility, joint laxity, and tissue fragility. Genetic defects have been identified in type I collagen, type III collagen, type V collagen, and lysyl hydroxylase, with variable phenotypic results. In addition to an increase in general surgical complications, such as wound dehiscence, poor scarring, and intra- or postoperative bleeding,^[@R7],\ [@R8]^ patients purportedly also have an increase in inguinal hernias and recurrent ventral hernias.

Whereas Marfan's syndrome is not defined by defects in collagen synthesis, a mutation in fibrillin in these patients results in abnormalities in the extracellular matrix and connective tissues. Common phenotypic abnormalities include dolichostenomelia, arachnodactyly, scoliosis, and joint flexibility.^[@R9]^ Marfan's syndrome can also result in aortic or mitral prolapse, aortic dissection, spontaneous pneumothorax, and early cataracts or glaucoma. To better understand disorders of collagen production, organization, and degradation, it is paramount to briefly review relevant normal processes before discussing the abnormal processes. Produced by fibroblasts, collagen is the most abundant mammalian protein and the principal component of connective tissue. Its production requires a complex series of steps involving multiple enzymes and cellular organelles to reach a final product. Each of these steps is complex, and any defect in this process can lead to subpar collagen production, which given the multitude of tissues that collagen is present in can lead to many clinical manifestations.

In addition to its production for normal tissue maintenance and turnover, collagen plays a principal role in wound healing. This process is particularly relevant in the healing of postsurgical wounds and signals a potential causative factor in the development of incisional hernias. In response to platelet derived growth factor and other growth factors, fibroblasts begin the synthesis of a provisional matrix composed of type III collagen and glycosaminoglycans.^[@R10]^ Although collagen in uninjured skin is 80--90% type I and 10--20% type III, initial fibroblast production is preferentially skewed toward type III collagen.^[@R11]^ This type of collagen is critical during the initial wound healing period to allow for colocalization and proper fibrillogenesis to the more common type I collagen.^[@R12]^

METHODS
=======

A systematic literature review was performed of the PubMed and Cochrane databases. Article selection was limited to English and Spanish language articles published between January 1, 1946 and June 1, 2014. Abstracts were reviewed by B.H. and K.S. and articles were reviewed in full if there was any question about meeting inclusion criteria. Inclusion criteria consisted of all articles that discussed the relationship between abdominal wall hernias and quantitative or qualitative abnormalities in collagen. Exclusion criteria included articles that discussed only collagen disorders or only hernias, or only mentioned a possible correspondence between hernias and collagenopathies. Articles that reviewed symptoms of collagenopathies but did not discuss hernias were also excluded. Our initial search terms included "hernia" or "hernia, abdominal" or "hernia, inguinal" or "hernia, ventral" or "hernia, umbilical" or "gastroschisis" or "hernia, femoral" or "hernia, diaphragmatic" or "hernia, diaphragmatic, traumatic" or "hernia, hiatal" or "herniorrhaphy" or "collagen diseases" or "Ehlers--Danlos syndrome" or "cutis laxa" or "marfan syndrome" or "collagenopathy" or "collagen defect" or "collagen type VI" or "collagen type VIII" or "collagen type II" or "collagen type VII" or "collagen type IX" or "collagen type I" or "collagen type" or "collagen type III" or "collagen type V" or "collagen type IV" or "fibrillar collagens" or "collagen". Despite their potential bias, case reports and animal studies were included due to the limited number of clinical studies thus far available.

SEARCH RESULTS
==============

Our initial search returned 352 published articles. After exclusion criteria were applied, 59 articles were included in the initial review. These articles were reviewed in their entirety by B.H. and K.S. to ensure relevant content for inclusion. Articles not returned in the initial search but with relevant citations in the included articles were also studied for content. A total of 61 articles met all inclusion (Fig. [2](#F2){ref-type="fig"}). Articles include 1 case-control study, 3 case reports, 37 prospective studies, 5 retrospective studies, 7 reviews, and 5 systematic reviews. Three of the articles were animal studies. The remainder were human studies (Table [1](#T1){ref-type="table"}). The variability in outcomes reported does not allow for quantitative analysis, and qualitative comparisons were drawn.
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EVIDENCE FOR COLLAGENOPATHIES IN HERNIAS
========================================

Inguinal
--------

Reports of hernia formation in patients with collagen vascular diseases suggest a plausible association between abnormal collagen content or structure and the presence of abdominal wall herniation. In patients with direct inguinal hernias, Wagh et al^[@R13]^ found that the anterior rectus sheath above the defect is thinner than normal, accounted for by a decrease in hydroxyproline (by 19.2%) and therefore collagen. This may be attributed to a decrease in proliferation of fibroblasts, as shown by culture of fibroblasts taken from the anterior rectus sheath. Collagen values for indirect hernias fell between control levels and patients with direct defects, and the same investigator concluded that adult hernias can be attributed to reduced collagen synthesis by fibroblasts.^[@R14]^ Perhaps as a consequence of the altered proline ratio and hydroxylation defect, a marked variation in the diameter of fibrils from patients with direct hernia was observed.

Studies performed on the transversalis fascia of patients with hernia have supported abnormalities in collagen content. Conner and Peacock found that combining the effect of chemically induced lathyrism and injury to the internal ring produced progressive enlargement of the ring and herniation in rats. In contrast, isolated lathyrism or anatomic injury alone did not reliably produce inguinal herniation. This suggests that if even a small anatomic defect exists, a crosslinking deficiency will predispose the patient to inguinal herniation.^[@R15]^ In a more recent evaluation of human transversalis fascia, its extensibility and elasticity were also significantly increased in patients with direct hernias. This was true in samples from the nonherniated sides as well, suggesting a preclinical pathologic state.^[@R16]^

Casanova et al^[@R17]^ found 17.3% less total and 23.7% less type I collagen in the transversalis fascia of patients with indirect inguinal hernias. Reduced collagen and elastin were also found in rectus sheath and peritoneal samples from patients with direct and indirect hernia.^[@R18]^ The authors suggest that this finding reflects a more generalized, or at least regional, connective tissue disorder.

As detailed above, type III collagen also plays a role in the formation of a regular, repetitive array of fibrils in a normal extracellular matrix. In addition to possible defects in hydroxylation and modification of collagen in patients with hernia, some authors have identified an increase in type III collagen synthesis.^[@R19]--[@R21]^ A case-control study of 27 patients with inguinal hernia and 24 controls by Meyer et al^[@R22]^ showed a relative increase in the quantity of type III collagen in patients with hernia. This increase in patients with hernia may contribute to irregular synthesis of type I collagen fibrils. As type III collagen is also considered to be the thinner, more immature form of collagen, offering less tensile strength than type I collagen, this altered ratio could theoretically contribute to weakness of fascial or aponeurotic tissues. When this ratio is compared between direct and indirect hernias, no significant difference was found, suggesting a common collagen abnormality in their development.^[@R23]^ However, Pans et al^[@R24]^ identified no qualitative difference in type I:III collagen ratios between control subjects and patients with hernia.

Ventral Hernias
---------------

Ventral hernia formation has also been linked with abnormal collagen synthesis. Reduced collagen synthesis may be directly related to the function of the N-propeptide of collagen I. Twenty percent of mice with deletions encoding this sequence developed abdominal hernias within the first 2 months of life and were found to have thin dermis with fewer large collagen fibers. Fachinelli and Maciel Trindade^[@R25]^ found 20.5% less type I and 18.5% less total collagen content in the linea alba of patients with ventral hernia.

Pathologic changes may not be solely attributed to pathologic collagen fibers, but also to the role of elastic fibers. In an immunohistochemical analysis of the linea alba from patients with abdominal wall hernia, investigators suggested an inverse relationship between the quantity of collagen and elastic fibers. In a combination of epigastric, incisional, and umbilical hernias, the amount of elastin was significantly increased although the structure of the elastic fibers was altered, demonstrating a fragmented, thickened shape in patients with ventral hernia.^[@R26]^

Combined Evidence in Different Etiologies
-----------------------------------------

An analysis of 12 patients with recurrent incisional hernias and 11 control subjects without any history of hernia confirmed a decreased collagen I/III ratio in the skin of patients with hernia (0.88 versus 0.98), but this was not observed in fascial biopsies.^[@R27]^ Multiple studies have shown decreased collagen I/III ratios in mature skin scars from patients with either primary or recurrent incisional hernias compared with mature abdominal skin scars from patients without hernias^[@R23],\ [@R28]--[@R31]^ and in periprosthetic scar of recurrent inguinal and incisional hernias.^[@R32]^ A common link between all hernias has been found by some studies including differing etiologies. Ozdemir et al^[@R33]^ included indirect, direct, and incisional hernias in their evaluation of copper and zinc levels. Because some of the enzymes responsible for collagen production and processing require the presence of zinc and copper for proper function, deficiencies in these minerals have been proposed as a contributing factor to hernia formation. Lower tissue levels of copper and zinc were found in all examined hernias, despite having similar plasma levels. The authors suggest a possible dysfunction or excessive consumption of lysyl oxidase as the underlying etiology.^[@R33]^ This opens a possible role for supplementation of these minerals in postoperative patients, although such intervention has not been proven.

The relative influence of these biologic abnormalities to direct, indirect, or incisional hernias is not currently clear. Although current data tend to support an inherent defect in collagen metabolism and structure, it is not evident that this plays an equivalent role among all hernia etiologies. A 2011 review of 52 papers found more pronounced changes in patients with direct inguinal hernias than in indirect, recurrent, or incisional hernias.^[@R34]^ However, these authors report a consistent increase in immature type III collagen relative to type I collagen, a finding which was not universally found in our review. How these changes result in hernia development is also not well-defined, as a biomechanical study of the transversalis fascia found no significant difference between break stress, strain, or modulus in herniated or nonherniated fascia.^[@R35]^ Neither were significant differences found in average collagen fibril diameter or density.

HERNIAS AND COLLAGEN VASCULAR DISEASE
=====================================

Numerous defects in collagen synthesis or degradation have been associated with clinical disease (Table [1](#T1){ref-type="table"}) and lend support to primary collagen dysfunction as a fundamental factor in hernia formation.

Ehlers--Danlos Syndrome
-----------------------

Due to the variable manifestations and difficult clinical diagnosis of Ehlers-Danlos syndrome, there are relatively few analyses of the exact incidence of herniation in this population. However, a 1997 survey of 130 affected patients in the Netherlands identified a crude rate ratio of inguinal herniation of 2.5.^[@R36]^ Among 100 patients with Ehlers--Danlos syndrome surveyed in 1969, 11 reported having had an inguinal hernia repair. However, this report did not offer a control group for reference.^[@R7]^ A more recent retrospective chart review of patients presenting for recurrent abdominal wall herniation at a tertiary institution found a 10% incidence rate, which was much higher than what the authors expected.^[@R37]^ The literature is otherwise peppered with case reports of large and difficult hernias,^[@R38]^ but does not allow for the evaluation of the case prevalence within the context of this patient population.

Patients with vascular Ehlers-Danlos syndrome have a high incidence of abdominal aortic aneurysms (AAAs), a pathologic dilation of the abdominal aorta also tied to abnormalities in connective tissue. The general population of patients with AAAs is also at high risk for abdominal wall herniation and offers a more easily studied group due to the disease's prevalence. When comparing patients having aortic reconstruction for aortoiliac occlusive disease versus patients with AAAs, studies report postoperative incisional hernias in 10% to 37% of patients with AAAs versus 3% to 19% patients having aortic reconstruction for aortoiliac occlusive disease.^[@R39]^ A meta-analysis of postoperative incisional hernia patients with AAA and aortoiliac occlusive disease undergoing abdominal aortic reconstruction also noted a nearly 3-fold increased risk of postoperative incisional hernia in patients with AAA. They also reported a 3-fold increased risk of inguinal hernia.^[@R40]^ Like hernias, aortic aneurysms have been associated with increased activity of matrix metalloproteinase (MMP)-1 and MMP-13.^[@R41]^ A similar aberration in type III collagen synthesis and turnover has also been observed in the pathogenesis of AAA.^[@R42]^

Repair in collagenopathies is similar to standard hernia repair. In their description of ventral hernia repair in two patients with Ehlers--Danlos syndrome, Girotto et al^[@R37]^ utilized the components separation technique with a polypropylene (Marlex, Bard Davol, R.I.) mesh overlay. Neither patient experienced a recurrence at the time of their publication, but the duration of follow-up is not specified. Based on their level IV evidence, the authors proposed the use of polypropylene in these patients to reduce incidence of wound failure and hernia recurrence by generating additional fibrosis.

Marfan's Syndrome
-----------------

Data on the incidence of hernias in patients with Marfan's syndrome are lacking, but case reports indicate a higher occurrence of herniation at uncommon sites. Examples of these rarities include intrathoracic stomach (gastric herniation)^[@R43]^ and neonatal hiatal/paraesophageal hernias.^[@R44]^ A review of patients with Marfan's syndrome who underwent aortic aneurysm repair over 26 years revealed a 32% incidence of inguinal hernia.^[@R45]^ Other reports vary from 22% to 42%.^[@R46],\ [@R47]^ Slight differences in the pattern of fibrillin-1 deposition in tissue samples from skin and fascia in non-Marfan incisional hernia patients has been observed, but these differences were hardly quantifiable.^[@R48]^ Future studies on this limited population will help to clarify the impact of other connective tissue diseases on abdominal wall herniation.

TREATMENT OPTIONS
=================

Despite advances in surgical technique and available surgical adjuncts, such as prosthetic and biologic meshes, surgeons continue to battle with patients who present with recurrent herniation. Optimal repair is even more important in this population of patients with known collagen vascular disease that are inherently set up for higher rates of recurrence.

Newer biologic meshes offer the theoretic advantage of providing a framework on which matrix remodeling and collagen deposition may occur. The data on biologic mesh are still highly debated, and the effect of various processing methods and crosslinking agents may affect the body's response to these materials.^[@R49]^ Even with sturdy biology or synthetic support, each interface of fixation requires healing. Although mechanically durable and infection resistant in vitro, a biologic mesh placed in vivo in a patient population with established abnormalities in collagen deposition and remodeling may generate an altered, suboptimal, or distinct response from that observed in laboratory studies.

A potential target for future exploration is the precoated synthetic material, which incorporates the advantages of synthetic mesh with a fibroblast coating. Although the authors of a 2005 feasibility study suggest a potential decrease in adhesions and fistulas with this material,^[@R50]^ their reports of increased type I collagen expression and a low rate of type III collagen production offer an additional advantage in the collagen-deficient abdominal hernia. Other biomaterials are still in development, such as fibroblast-seeded polyglycolic acid scaffolds^[@R51]^ and mesenchymal stem cell--seeded scaffolds.^[@R52]^ Theoretically, introducing the biologic components necessary for normal collagen production and remodeling would offer the best chance at hernia repair and prevention of recurrence. Unfortunately, these specialized advances in tissue engineering have yet to reach the human stages of evaluation and lack evaluation even in uncomplicated patients with hernia.

Additional screening of MMP expression and blood levels might further stratify patients and allow for selection of patients who might benefit from additional technologies. Given the MMP abnormalities described in patients with hernia, such technologies may include administration of MMP inhibitors. This has been evaluated in patients with AAAs,^[@R53]^ cancer,^[@R54]^ and arthritis,^[@R55]^ but no studies have been performed on patients with hernia. There are several types of pharmacological MMP inhibitors, the most common of which are tetracycline derivatives. Doxycycline is a nonspecific MMP inhibitor and can be prescribed at low, subantibiotic doses, which limits unwanted side effects. Thus far, however, the use of these drugs is experimental and data are lacking. Genetic profiling is also potentially beneficial for risk stratification, given known abnormalities in collagen gene expression.^[@R56]^ However, these developments are far from clinical use.

Until that time when defective fibroblasts and inherited enzyme abnormalities can be replaced with genetic or tissue engineering, the surgeon should optimize repair with available mesh and local tissue and apprise the patient on all inherent risks. Given the above information, patients with hernia, and especially those with inherited collagen vascular disease, likely have altered collagen production and processing, predisposing these patients to a high risk of recurrence. By explaining the biologic defect involved in hernia formation, the patient may be more understanding of this risk. That said, successful repair is possible, even without genetic tests and enzyme alteration, and with proper informed consent, the prepared surgeon can offer mechanical optimization of a complex biomechanical disease.

LIMITATIONS
===========

The inclusion of all hernias, including incisional, ventral, and inguinal, in this review introduces multiple etiologies which may complicate a clear distinction as to a common pathophysiology in collagen formation. Variable stages in healing between multiply operated patients and a primary hernia will also confound collagen formation. In addition, although we included animal studies for completion, their findings may not be universally applicable to humans. The small number of publications on hernias in patients with diagnosed collagen vascular disorders also limits conclusions about outcomes and complications in these patients.

CONCLUSIONS
===========

High-level clinical data clearly explaining the link between collagenopathies and hernia formation are lacking. However, there is a trend in pathologic studies suggesting a link between abnormal collagen production and/or processing that at least plays a role in the development of direct, indirect, and ventral hernias. The contribution of these abnormalities in reference to different anatomic locations and patient populations is variable, but will be important for patient education and continued investigation into therapeutic modalities.
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